Invalid Symbol

Stock Research for KBIO

KBIO
Current Price

$


Latest Update:

High
$
Low
$
Close
$
Volume
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

KBIO Stock Chart & Research Data

The KBIO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the KBIO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


KBIO Due diligence Resources & Stock Charts

The KBIO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View KBIO Detailed Price Forecast - CNN Money CNN View KBIO Detailed Summary - Google Finance
Yahoo View KBIO Detailed Summary - Yahoo! Finance Zacks View KBIO Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View KBIO Trends & Analysis - Trade-Ideas Barrons View KBIO Major Holders - Barrons
NASDAQ View KBIO Call Transcripts - NASDAQ Seeking View KBIO Breaking News & Analysis - Seeking Alpha
Spotlight View KBIO Annual Report - CompanySpotlight.com OTC Report View KBIO OTC Short Report - OTCShortReport.com
TradeKing View KBIO Fundamentals - TradeKing Charts View KBIO SEC Filings - Bar Chart
WSJ View Historical Prices for KBIO - The WSJ Morningstar View Performance/Total Return for KBIO - Morningstar
MarketWatch View the Analyst Estimates for KBIO - MarketWatch CNBC View the Earnings History for KBIO - CNBC
StockMarketWatch View the KBIO Earnings - StockMarketWatch MacroAxis View KBIO Buy or Sell Recommendations - MacroAxis
Bullish View the KBIO Bullish Patterns - American Bulls Short Pains View KBIO Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View KBIO Stock Mentions - StockTwits PennyStocks View KBIO Stock Mentions - PennyStockTweets
Twitter View KBIO Stock Mentions - Twitter Invest Hub View KBIO Investment Forum News - Investor Hub
Yahoo View KBIO Stock Mentions - Yahoo! Message Board Seeking Alpha View KBIO Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for KBIO - SECform4.com Insider Cow View Insider Transactions for KBIO - Insider Cow
CNBC View KBIO Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for KBIO - OTC Markets
Yahoo View Insider Transactions for KBIO - Yahoo! Finance NASDAQ View Institutional Holdings for KBIO - NASDAQ


Stock Charts

FinViz View KBIO Stock Insight & Charts - FinViz.com StockCharts View KBIO Investment Charts - StockCharts.com
BarChart View KBIO Stock Overview & Charts - BarChart Trading View View KBIO User Generated Charts - Trading View


Latest Financial News for KBIO

JGR Capital Partners Initiates Coverage on KaloBios Pharmaceuticals Inc.
Posted on Tuesday May 02, 2017

NEW YORK, NY / ACCESSWIRE / May 2, 2017 / JGR Capital Partners, a leading equity research and digital investor relations firm, has announced it has initiated coverage on KaloBios (OTC PINK: KBIO) with ...


Rare Diseases Patients Need More Than Miracles And Trumpcare
Posted on Saturday March 11, 2017

Rare Disease Week was rapidly followed by more proposals to gut the ACA healthcare and the FDA, immigration and travel bans which will decimate research and healthcare (as well as being needless and cruel), and reduce research budgets. How does this help patients?



Posted on Wednesday December 31, 1969



Posted on Wednesday December 31, 1969


KaloBios To Change Company Name To Humanigen, Inc.
GlobeNewswire (press release) - Jul 27, 2017
BRISBANE, Calif., July 27, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTCQB:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today announced it will change the company's name ...

Humanigen Signs Definitive Agreements to Exchange Loan Obligations for Equity
GlobeNewswire (press release) - Dec 21, 2017
BRISBANE, Calif., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company pursuing cutting-edge science to develop its proprietary monoclonal antibodies for immunotherapy and oncology treatments, today announced it ...

Humanigen Appoints Rainer Boehm, MD, to Board of Directors
GlobeNewswire (press release) - Feb 7, 2018
Humanigen, Inc. is a biopharmaceutical company pursuing cutting-edge science to develop its proprietary monoclonal antibodies for immunotherapy and oncology treatments.

Humanigen CEO to Present at NobleCon14, BIO CEO Investor Conferences
GlobeNewswire (press release) - Jan 25, 2018
BRISBANE, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company pursuing cutting-edge science to develop its proprietary monoclonal antibodies for immunotherapy and oncology treatments, announced today that ...

Enter a stock symbol to view the stock details.